For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Vitamin B12 deficiency not uncommon
Vitamin B12 deficiency not uncommon

An elderly patient’s pancytopenia and severe anaemia raises the possibility of bone marrow malignancy, but her full lab results reveal other possible causes
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. Wickramasinghe S. Diagnosis of megaloblastic anaemias. Blood Rev 2006;20:299–318.
2. Dali-Youcef N, Andres E. An update on cobalamin deficiency in adults. Quart J Med 2009;102:17–28.
3. Schirier S. Diagnosis and treatment of B12 and folate deficiency. Aetiology and clinical manifestations of vitamin B12 and folate deficiency. UpToDate Online
4. Devalia V, Hamilton MS, Molloy AM. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol 2014;166:496–513.
5. Wong CW. Vitamin B12 deficiency in the elderly: Is it worth screening. Hong Kong Med J 2015;21(2):155–64.